Skip to main content
. 2020 Aug 21;26(31):4607–4623. doi: 10.3748/wjg.v26.i31.4607

Table 1.

General characteristics of patients and healthy controls

Characteristics C (n = 30) Y (n = 29) N (n = 31) P value
Sex (Male/Female) 25/5 21/8 25/6 0.565
Age (yr) 52.93 ± 11.01 56.63 ± 9.15 51.23 ± 11.79 0.148
Pathogens HBV 25 24 / 0.720
HCV 1 2
HBV + HCV 1 0
None 3 3
AFP (ng/mL) > 200 11 0 / 0.000
50-199 4 1
< 50 15 28
ALT (U/L) 162.32 ± 201.06 91.02 ± 156.39 20.34 ± 8.43 0.000
AST (U/L) 146.35 ± 112.70 114.49 ± 191.67 21.59 ± 4.51 0.012
TBIL (μmol/L) 39.21 ± 68.38 40.87 ± 42.41 9.66 ± 2.66 0.015
DBIL (μmol/L) 17.91 ± 34.43 17.90 ± 23.03 4.49 ± 1.38 0.044
TP (g/L) 62.42 ± 10.95 74.14 ± 8.05 72.31 ± 3.96 0.000
ALB (g/L) 33.51 ± 6.30 37.65 ± 7.64 45.36 ± 2.62 0.000
Child-Pugh score (A/B) 18/12 15/14 / 0.353

AFP: α-fetoprotein; ALB: Albumin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; DBIL: Direct bilirubin; TBIL: Total bilirubin; TP: Total protein.